Potassium Channel: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 58: | Line 58: | ||
**[[1a68]], [[1eod]], [[1eoe]], [[1eof]], [[3kvt]] - AcKCh Kv1.1 T1 domain (mutant) - ''Aplysia californica''<br /> | **[[1a68]], [[1eod]], [[1eoe]], [[1eof]], [[3kvt]] - AcKCh Kv1.1 T1 domain (mutant) - ''Aplysia californica''<br /> | ||
**[[1t1d]] - AcKCh Kv1.1 T1 domain<br /> | **[[1t1d]] - AcKCh Kv1.1 T1 domain<br /> | ||
**[[6eo1]] - MlotiK1 + K – ''Mesorhizobium loti''<br /> | |||
**[[3co2]], [[1vp6]] - MlotiK1 cyclic nucleotide binding domain - ''Mesorhizobium loti''<br /> | **[[3co2]], [[1vp6]] - MlotiK1 cyclic nucleotide binding domain - ''Mesorhizobium loti''<br /> | ||
**[[1ho2]], [[1ho7]] - | **[[1ho2]], [[1ho7]] - DmKCh L45 segment - ''Drosophila melanogaster'' - NMR<br /> | ||
**[[2kyh]] - AeKCh voltage ensing domain - ''Aeropyrum pernix'' - NMR<br /> | **[[2kyh]] - AeKCh voltage ensing domain - ''Aeropyrum pernix'' - NMR<br /> | ||
**[[2wll]] - KCh KIRBAC1.1 - ''Burkholderia pseudomalie''<br /> | **[[2wll]] - KCh KIRBAC1.1 - ''Burkholderia pseudomalie''<br /> | ||
| Line 72: | Line 73: | ||
**[[2a79]], [[1qrq]] - rKCh Kv1.2 + beta2<br /> | **[[2a79]], [[1qrq]] - rKCh Kv1.2 + beta2<br /> | ||
**[[4jta]], [[4jtc]], [[4jtd]] - rKCh Kv1.2-2.1 + KCh toxin <br /> | **[[4jta]], [[4jtc]], [[4jtd]] - rKCh Kv1.2-2.1 + KCh toxin <br /> | ||
**[[2r9r]] - rKCh<br /> | **[[2r9r]] - rKCh Kv2.1/KCh Kv1.2 + Kv β-2<br /> | ||
**[[1exb]] - rKCh Kv1.1 T1 domain + KV beta2 protein<br /> | **[[1exb]] - rKCh Kv1.1 T1 domain + KV beta2 protein<br /> | ||
**[[2p7t]] - rKCh + FAV<br /> | **[[2p7t]] - rKCh + FAV<br /> | ||
**[[3lnm]] - rKCh Kv2.1/KCh Kv1.2 (mutant)<br /> | **[[3lnm]], [[6ebl]], [[6ebk]] - rKCh Kv2.1/KCh Kv1.2 (mutant)<br /> | ||
**[[5k7l]] - rKCh EAG1 + calmodulin <br /> | |||
**[[3eff]] - mKCh + FAB <br /> | **[[3eff]] - mKCh + FAB <br /> | ||
**[[2w0f]] - mKCh + FAB + tetraoctylammonium<br /> | **[[2w0f]] - mKCh + FAB + tetraoctylammonium<br /> | ||
| Line 82: | Line 84: | ||
**[[3f5w]], [[1zwi]], [[2hjf]] - mKCh (mutant) + antibody heavy+light chains<br /> | **[[3f5w]], [[1zwi]], [[2hjf]] - mKCh (mutant) + antibody heavy+light chains<br /> | ||
**[[1k4c]], [[1k4d]], [[4lcu]], [[5ec2]], [[5ec1]], [[5ebw]], [[5ebm]], [[5ebl]], [[5e1a]], [[4lbe]] - SlKCh Kcsa (mutant) + antibody <br /> | **[[1k4c]], [[1k4d]], [[4lcu]], [[5ec2]], [[5ec1]], [[5ebw]], [[5ebm]], [[5ebl]], [[5e1a]], [[4lbe]] - SlKCh Kcsa (mutant) + antibody <br /> | ||
**[[3pjs]], [[5j9p]], [[4uuj]], [[4msw]], [[4lbe]] – SlKCh Kcsa + antibody<br /> | **[[3pjs]], [[5j9p]], [[4uuj]], [[4msw]], [[4lbe]], [[5vkh]], [[5vke]], [[5vk6]] – SlKCh Kcsa + antibody<br /> | ||
**[[2a9h]] - SlKCh Kcsa (mutant) + charybdotoxin<br /> | |||
**[[2a0l]] - AeKCh + FV<br /> | **[[2a0l]] - AeKCh + FV<br /> | ||
**[[1orq]] - AeKCh (mutant) + FAB<br /> | **[[1orq]] - AeKCh (mutant) + FAB<br /> | ||
**[[5vms]] - KCh Kv7.1 + calmodulin - frog <br /> | **[[5vms]] - KCh Kv7.1 + calmodulin - frog <br /> | ||
**[[ | **[[5hu3]], [[5h9b]], [[5fg8]] - DmKCh EAG + CAMKII <br /> | ||
*Human potassium Channel | *Human potassium Channel | ||
| Line 108: | Line 110: | ||
**[[4v0c]] - hKCh Kv7.1 + calmodulin <br /> | **[[4v0c]] - hKCh Kv7.1 + calmodulin <br /> | ||
**[[4umo]] - hKCh Kv7.1 (mutant) + calmodulin <br /> | **[[4umo]] - hKCh Kv7.1 (mutant) + calmodulin <br /> | ||
**[[5j03]] - hKCh Kv7.2 + calmodulin <br /> | **[[5j03]], [[6feh]], [[6feg]] - hKCh Kv7.2 + calmodulin <br /> | ||
**[[6b8p]], [[6b8n]], [[6b8m]], [[6b8l]] - hKCh Kv7.4 + calmodulin <br /> | |||
**[[6b8q]] - hKCh Kv7.5 + calmodulin <br /> | |||
*Inward rectifier KCh | *Inward rectifier KCh | ||
| Line 123: | Line 127: | ||
**[[3syq]] - mIRK 3.2 (mutant) + PIP2<br /> | **[[3syq]] - mIRK 3.2 (mutant) + PIP2<br /> | ||
**[[4kfm]] - mIRK 3.2 + guanine nucleotide-biding protein<br /> | **[[4kfm]] - mIRK 3.2 + guanine nucleotide-biding protein<br /> | ||
**[[5wua]], [[5twv]] - mIRK 11 + sulfonylurea receptor<br /> | **[[5wua]], [[5twv]] - mIRK 11 + sulfonylurea receptor - Cryo EM<br /> | ||
**[[5ywc]], [[5ywb]] - mIRK 11 + sulfonylurea receptor + ADP – Cryo EM<br /> | |||
**[[5ywa]], [[5yw9]], [[5yw8]] - mIRK 11 + sulfonylurea receptor + ATP – Cryo EM<br /> | |||
**[[6c3p]], [[6c3o]] - hIRK 11 + sulfonylurea receptor + ATP + ADP – Cryo EM<br /> | |||
**[[6baa]] - hIRK 11 + sulfonylurea receptor + ATP + glibenclamide – Cryo EM<br /> | |||
**[[5twv]] - rIRK 11 + sulfonylurea receptor + ATP + glibenclamide – Cryo EM<br /> | |||
**[[5ykg]], [[5ykf]], [[5yke]] - mIRK 11 + sulfonylurea receptor + ATP + glibenclamide – Cryo EM<br /> | |||
**[[1xl4]], [[1xl6]], [[2wlk]], [[2x6a]], [[2x6b]], [[2x6c]] - MmIRK KIRBAC3.1<br /> | **[[1xl4]], [[1xl6]], [[2wlk]], [[2x6a]], [[2x6b]], [[2x6c]] - MmIRK KIRBAC3.1<br /> | ||
**[[4lp8]] - MmIRK KIRBAC3.1 (mutant) <br /> | **[[4lp8]] - MmIRK KIRBAC3.1 (mutant) <br /> | ||
| Line 143: | Line 153: | ||
**[[4bw5]], [[4xdj]] – hKCh TREK-2<br /> | **[[4bw5]], [[4xdj]] – hKCh TREK-2<br /> | ||
**[[4xdl]], [[4xdk]] – hKCh TREK-2 + Prozac derivative<br /> | **[[4xdl]], [[4xdk]] – hKCh TREK-2 + Prozac derivative<br /> | ||
**[[6cq9]] – mKCh TREK-1<br /> | |||
**[[5vkp]], [[6cq8]], [[6cq6]] – mKCh TREK-1 (mutant)<br /> | **[[5vkp]], [[6cq8]], [[6cq6]] – mKCh TREK-1 (mutant)<br /> | ||
| Line 170: | Line 181: | ||
**[[3naf]] – hKCh α1 subunit<br /> | **[[3naf]] – hKCh α1 subunit<br /> | ||
**[[4hpf]] - hKCh α 3 subunit<br /> | **[[4hpf]] - hKCh α 3 subunit<br /> | ||
**[[5y7l]] - hKCh β 4 subunit extracellular loop<br /> | |||
*Small conductance calcium-activated KCh | *Small conductance calcium-activated KCh; Domains - calmodulin-binding 395-487; leucine zipper 488-526 | ||
**[[1kkd]] – rKCh calmodulin-binding domain - NMR <br /> | **[[1kkd]] – rKCh calmodulin-binding domain - NMR <br /> | ||
**[[3sjq]], [[4g27]], [[4g28]], [[4j9y]], [[4j9z]], [[1g4y]], [[4qnh]] - rKCh calmodulin-binding domain + calmodulin<br /> | **[[3sjq]], [[4g27]], [[4g28]], [[4j9y]], [[4j9z]], [[1g4y]], [[4qnh]], [[1qx7]], [[6czq]] - rKCh calmodulin-binding domain + calmodulin<br /> | ||
**[[ | **[[2pnv]] – rKCh leucine zipper domain SKCa <br /> | ||
**[[ | **[[6ale]], [[5v03]], [[5v02]] - hKCh SKCa2 calmodulin-binding domain + calmodulin<br /> | ||
**[[5wc5]], [[5wbx]] - hKCh SKCa2 calmodulin-binding domain (mutant) + calmodulin<br /> | |||
*Intermediate conductance calcium-activated KCh | |||
**[[6cno]], [[6cnn]], [[6cnm]] - hKCa 3.1 + calmodulin – Cryo EM<br /> | |||
**[[6d42]]- rKCa 3.1 C terminal<br /> | |||
*Potassium/Sodium hyperpolarization-activated cyclic nucleotide-gated channel or cyclic nucleotide-gated channel or HCN channel see [[Ion channels]] | *Potassium/Sodium hyperpolarization-activated cyclic nucleotide-gated channel or cyclic nucleotide-gated channel or HCN channel see [[Ion channels]] | ||
Revision as of 06:49, 26 August 2018
| ||||||||||||
Page Development
This article was developed based on lectures given in Chemistry 543 by Prof. Clarence E. Schutt at Princeton University.
Potassium channels (KCh) are subdivided into voltage-gated KCh and calcium-dependent KCh. The latter are subdivided into high- (BK, LKCa), intermediate- and small-conductance KCh (human SK1, rat SK2, SKCa). The T1 domain is a highly conserved N-terminal domain which is responsible for driving the tetramerization of the KCh α subunit. The inward rectifier KCh (IRK) passes current more easily in the inward direction. MthK is a calcium-dependent KCh from Methanobacterium thermoautrophicum.
3D structures of Potassium Channels
Updated on 26-August-2018
Additional Resources
References
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Ann Taylor, Michal Harel, Joel L. Sussman